SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Asthma/Allergy
An SI Board Since March 2001
Posts SubjectMarks Bans
86 25 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
36Hybridon joins the CpG wars....... Message 18037683scaram(o)uche-9/26/2002
35<i>http://www.newswire.ca/releases/August2002/22/c4812.html</i> PPLrusset-8/22/2002
34Cell Signal 2001 Apr;13(4):287-97 Identification of inhibitor binding sites ofscaram(o)uche-7/10/2002
33GSK / elbion / AWD12-281 LONDON, July 10 (Reuters) - Britain's GlaxoSmithKlnigel bates-7/10/2002
32Dynavax Initiates First Human Trial of ISS for Asthma BERKELEY, Calif., May 20 nigel bates-5/20/2002
31Here's the abstract. I know Andy Saxon, which means that he's been arouscaram(o)uche-5/16/2002
30Tanox, Inc. Announces Positive Preliminary Results in Peanut Trial HOUSTON, May keokalani'nui-5/1/2002
291 May 2002 -- Scientists supported by the National Institute of Allergy and Infenigel bates-5/1/2002
28149 'asthma genes'... 4/11/2002 -- Research published in this month'nigel bates-4/11/2002
27<This is not the SEPR thread........ please avoid posts that deal with markeMike McFarland-4/7/2002
26Allegra aventispharma-us.com Claritin claritin.com A good pdf--suggests to me Mike McFarland-4/2/2002
25[CpG-rich DNA conjugates/ragweed/Dynavax] EMERYVILLE, Calif., March 20 /PRNewswnigel bates-3/20/2002
24[IL- Mab. Genaera and Medi.] Genaera Announces Two Presentations Demonstratingkeokalani'nui-3/4/2002
23[CpG-rich DNA conjugates/ragweed/Dynavax] Saturday March 2, 5:00 pm Eastern Timscaram(o)uche-3/4/2002
22IDPH's Zevalin received FDA marketing approval yesterBipin Prasad-2/21/2002
21EpiGenesis Announces Positive Data in Trial of EPI-2010 In Patients with Asthma nigel bates-1/23/2002
20A list of Asthma meds freebreather.com Recently I was a little surprised that mMike McFarland-12/27/2001
19Suggest listening to OSIP presentation for analyst's day, re. selective adenscaram(o)uche-11/26/2001
18[ anti-CD25 for asthma/PDLI ] Monday November 26, 4:00 pm Eastern Time Press Rscaram(o)uche-11/26/2001
17LONDON (Reuters Health) Oct 22 - Genetic factors have a greater influence than enigel bates-10/29/2001
16[ OSIP/asthma ] Message 16478430scaram(o)uche-10/9/2001
15Protein Design Labs Begins Phase II Study Of Humanized Anti-IL-4 Antibody In Astnigel bates-10/9/2001
14Slightly off topic. Interleukin-4 Pivotal in Development of Transplant ArteriosMiljenko Zuanic-8/14/2001
13Cambridge Antibody Technology (LSE: CAT: NASDAQ: CATG) today announced that a Phnigel bates-6/12/2001
12CAMBRIDGE, Mass., June 12 /PRNewswire/ -- Millennium Pharmaceuticals, Inc. (Nasdnigel bates-6/12/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News